INDOLE-3-BUTYRIC ACID


Synonyms	Indole-3-Butyric Acid
UNII	061SKE27JP
Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	JTEDVYBZBROSJT-UHFFFAOYSA-N
Smiles	OC(=O)CCCc1c[nH]c2ccccc12
InChI	InChI=1S/C12H13NO2/c14-12(15)7-3-4-9-8-13-11-6-2-1-5-10(9)11/h1-2,5-6,8,13H,3-4,7H2,(H,14,15)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C12H13NO2
Molecular Weight	203.24
AlogP	2.7
Hydrogen Bond Acceptor	2.0
Hydrogen Bond Donor	2.0
Number of Rotational Bond	4.0
Polar Surface Area	53.09
Molecular species	ACID
Aromatic Rings	2.0
Heavy Atoms	15.0

Assay Description	Organism	Bioactivity
Fungicidal activity against Fusarium culmorum assessed as inhibition of hyphal growth by radial growth test	Fusarium culmorum	576.0 ug.mL-1
Fungicidal activity against Pythium debaryanum assessed as inhibition of hyphal growth by radial growth test	Pythium debaryanum	249.0 ug.mL-1
Fungicidal activity against Rhizoctonia solani assessed as inhibition of hyphal growth by radial growth test	Rhizoctonia solani	644.0 ug.mL-1
Fungicidal activity against Macrophomina phaseoli assessed as inhibition of hyphal growth by radial growth test	Macrophomina phaseolina	699.0 ug.mL-1
Root formation-promoting activity in Vigna mungo (black gram) cuttings at 1 x 10'-4 M relative to IBA (Rvb = 35 +/- 8%)	Vigna mungo	100.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL582878
FDA SRS	061SKE27JP
PDB	3IB
PubChem	8617
SureChEMBL	SCHEMBL35884

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).